Loading...

Mirati Therapeutics, Inc. Peer Comparison

Metric Value Ranking
Market Cap $4.1 Billion 5/12 SRPT
$10.5B
MDGL
$7.4B
RETA
$6.6B
KRYS
$4.4B
MRTX
$4.1B
PTCT
$3.8B
APLS
$3.5B
VKTX
$3.3B
DAWN
$1.2B
ICPT
$794.7M
TERN
$368.6M
HEPA
$2.1M
Gross Margin 91% 6/12 ICPT
100%
MDGL
97%
RETA
96%
PTCT
92%
DAWN
92%
MRTX
91%
KRYS
90%
APLS
81%
SRPT
80%
VKTX
0%
HEPA
0%
TERN
0%
Profit Margin -100% 11/12 RETA
100%
DAWN
100%
KRYS
32%
SRPT
7%
VKTX
0%
HEPA
0%
TERN
0%
ICPT
-3%
APLS
-33%
PTCT
-79%
MRTX
-100%
MDGL
-100%
EBITDA margin -1049% 12/12 DAWN
148%
KRYS
27%
SRPT
5%
ICPT
-3%
APLS
-38%
PTCT
-40%
VKTX
-100%
HEPA
-100%
TERN
-100%
MDGL
-166%
RETA
-356%
MRTX
-1049%
Quarterly Revenue $16.4 Million 9/12 SRPT
$467.2M
APLS
$176.6M
PTCT
$135.4M
ICPT
$88.8M
KRYS
$83.8M
MDGL
$62.2M
RETA
$22.7M
DAWN
$20.1M
MRTX
$16.4M
VKTX
$0
HEPA
$0
TERN
$0
Quarterly Earnings -$161.9 Million 12/12 RETA
$193.0M
DAWN
$37.0M
SRPT
$33.6M
KRYS
$27.2M
ICPT
-$2.8M
HEPA
-$4.9M
TERN
-$21.9M
VKTX
-$24.9M
APLS
-$57.4M
PTCT
-$106.7M
MDGL
-$107.0M
MRTX
-$161.9M
Quarterly Free Cash Flow -$143.7 Million 12/12 KRYS
$57.8M
APLS
$34.1M
ICPT
$3.9M
HEPA
-$2.5M
DAWN
-$5.0M
TERN
-$16.5M
VKTX
-$22.0M
PTCT
-$22.8M
MDGL
-$62.8M
RETA
-$70.2M
SRPT
-$98.0M
MRTX
-$143.7M
Trailing 4 Quarters Revenue $38.2 Million 7/12 SRPT
$1.6B
PTCT
$839.3M
APLS
$675.9M
ICPT
$317.7M
KRYS
$241.5M
MDGL
$76.8M
MRTX
$38.2M
DAWN
$28.8M
RETA
$24.4M
VKTX
$0
HEPA
$0
TERN
$0
Trailing 4 Quarters Earnings -$716.6 Million 12/12 SRPT
$467.2M
APLS
$176.6M
PTCT
$135.4M
ICPT
$88.8M
KRYS
$83.8M
MDGL
$62.2M
RETA
$22.7M
DAWN
$20.1M
MRTX
$16.4M
VKTX
-$0
HEPA
-$0
TERN
-$0
Quarterly Earnings Growth 7% 9/12 RETA
362%
SRPT
182%
KRYS
182%
DAWN
180%
APLS
59%
HEPA
54%
TERN
26%
PTCT
20%
MRTX
7%
MDGL
-8%
VKTX
-11%
ICPT
-101%
Annual Earnings Growth -2% 8/12 SRPT
208%
KRYS
133%
RETA
72%
HEPA
57%
APLS
51%
DAWN
50%
PTCT
38%
MRTX
-2%
TERN
-6%
VKTX
-24%
MDGL
-46%
ICPT
-124%
Quarterly Revenue Growth 202% 2/12 RETA
2885%
MRTX
202%
APLS
78%
SRPT
41%
ICPT
14%
VKTX
0%
MDGL
0%
KRYS
0%
HEPA
0%
TERN
0%
DAWN
0%
PTCT
-31%
Annual Revenue Growth 77% 2/12 RETA
596%
MRTX
77%
APLS
76%
SRPT
47%
ICPT
8%
VKTX
0%
MDGL
0%
PTCT
0%
KRYS
0%
HEPA
0%
TERN
0%
DAWN
0%
Cash On Hand $258.7 Million 6/12 PTCT
$526.0M
DAWN
$422.8M
APLS
$396.9M
KRYS
$374.0M
TERN
$270.1M
MRTX
$258.7M
MDGL
$232.7M
SRPT
$197.9M
ICPT
$102.7M
VKTX
$50.3M
RETA
$48.8M
HEPA
$1.5M
Short Term Debt $8.0 Million 3/12 SRPT
$91.6M
PTCT
$16.8M
MRTX
$8.0M
APLS
$6.8M
RETA
$2.5M
HEPA
$2.2M
KRYS
$1.3M
MDGL
$878,000
VKTX
$480,000
TERN
$272,000
DAWN
$77,000
ICPT
-$0
Long Term Debt $42.2 Million 7/12 SRPT
$1.3B
PTCT
$383.5M
ICPT
$223.9M
RETA
$163.5M
MDGL
$118.3M
APLS
$104.7M
MRTX
$42.2M
DAWN
$2.5M
TERN
$1.0M
VKTX
$755,000
KRYS
$0
HEPA
$0
PE -1.00 3/12 SRPT
86.01
KRYS
83.10
MRTX
-1.00
VKTX
-1.00
RETA
-1.00
ICPT
-1.00
MDGL
-1.00
PTCT
-1.00
APLS
-1.00
HEPA
-1.00
TERN
-1.00
DAWN
-1.00
PS 107.82 2/12 RETA
269.17
MRTX
107.82
MDGL
96.59
DAWN
42.44
KRYS
18.02
SRPT
6.39
APLS
5.25
PTCT
4.50
ICPT
2.50
VKTX
-1.00
HEPA
-1.00
TERN
-1.00
PB 4.35 7/12 RETA
75.22
APLS
14.96
ICPT
11.06
MDGL
9.55
SRPT
8.58
KRYS
4.91
MRTX
4.35
VKTX
3.66
DAWN
2.20
TERN
1.01
PTCT
0.00
HEPA
0.00
PC 15.92 5/12 RETA
134.44
VKTX
66.31
SRPT
52.97
MDGL
31.89
MRTX
15.92
KRYS
11.64
APLS
8.94
ICPT
7.74
PTCT
7.17
DAWN
2.89
HEPA
1.42
TERN
1.36
Liabilities to Equity 0.19 6/12 RETA
4.76
ICPT
4.47
APLS
2.80
SRPT
1.95
MDGL
0.38
MRTX
0.19
KRYS
0.11
DAWN
0.08
TERN
0.04
VKTX
0.03
PTCT
0.00
HEPA
0.00
ROA -0.63 11/12 KRYS
5%
SRPT
3%
VKTX
-11%
ICPT
-15%
DAWN
-15%
RETA
-16%
TERN
-23%
PTCT
-25%
APLS
-28%
MDGL
-48%
MRTX
-63%
HEPA
-611%
ROE -0.76 9/12 HEPA
5583%
PTCT
43%
SRPT
10%
KRYS
6%
VKTX
-11%
DAWN
-16%
TERN
-24%
MDGL
-67%
MRTX
-76%
ICPT
-82%
RETA
-94%
APLS
-105%
Current Ratio 6.17 5/12 VKTX
35.47
TERN
27.48
DAWN
13.25
KRYS
10.18
MRTX
6.17
MDGL
3.62
SRPT
1.51
APLS
1.36
ICPT
1.22
RETA
1.21
HEPA
0.90
PTCT
0.64
Quick Ratio 5.33 5/12 SRPT
86.01
KRYS
83.10
MRTX
-1.00
VKTX
-1.00
RETA
-1.00
ICPT
-1.00
MDGL
-1.00
PTCT
-1.00
APLS
-1.00
HEPA
-1.00
TERN
-1.00
DAWN
-1.00
Long Term Debt to Equity 0.04 6/12 ICPT}
3.12
RETA}
1.87
SRPT}
1.07
APLS}
0.44
MDGL}
0.15
MRTX}
0.04
VKTX}
0.00
KRYS}
0.00
HEPA}
0.00
TERN}
0.00
DAWN}
0.00
PTCT}
-0.36
Debt to Equity 0.05 5/12 ICPT
3.12
RETA
1.90
SRPT
1.14
APLS
0.47
MRTX
0.05
VKTX
0.00
MDGL
0.00
KRYS
0.00
TERN
0.00
DAWN
0.00
PTCT
-0.38
HEPA
-5.47
Burn Rate 1.56 8/12 TERN
12.25
ICPT
8.75
APLS
6.27
SRPT
4.76
PTCT
4.17
MDGL
2.08
VKTX
2.01
MRTX
1.56
HEPA
0.28
RETA
-0.26
DAWN
-11.45
KRYS
-13.92
Cash to Cap 0.06 8/12 TERN
0.73
HEPA
0.70
DAWN
0.35
PTCT
0.14
ICPT
0.13
APLS
0.11
KRYS
0.09
MRTX
0.06
MDGL
0.03
VKTX
0.02
SRPT
0.02
RETA
0.01
CCR 0.89 2/12 KRYS
2.13
MRTX
0.89
VKTX
0.88
TERN
0.75
MDGL
0.59
HEPA
0.52
PTCT
0.21
DAWN
-0.13
RETA
-0.36
APLS
-0.59
ICPT
-1.38
SRPT
-2.91
EV to EBITDA -22.72 7/12 SRPT}
526.23
KRYS}
177.39
DAWN}
27.10
VKTX}
-1.00
HEPA}
-1.00
TERN}
-1.00
MRTX}
-22.72
APLS}
-48.28
PTCT}
-66.92
MDGL}
-69.79
RETA}
-82.50
ICPT}
-331.82
EV to Revenue 102.36 2/12 RETA
273.97
MRTX
102.36
MDGL
93.57
DAWN
27.86
KRYS
16.48
SRPT
7.12
APLS
4.82
PTCT
4.35
ICPT
2.88
VKTX
-1.00
HEPA
-1.00
TERN
-1.00